Adial Pharmaceuticals, Inc. Operating Leases, Rent Expense
Adial Pharmaceuticals, Inc. (ADIL) reported Operating Leases, Rent Expense of $3.90 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-02-19
- Adial Pharmaceuticals, Inc. operating leases, rent expense for the quarter ending 2018-12-31 was $0.00.
- Adial Pharmaceuticals, Inc. operating leases, rent expense for the quarter ending 2018-09-30 was $3.90K, a 420.00% increase year-over-year.
- Adial Pharmaceuticals, Inc. operating leases, rent expense for the quarter ending 2017-12-31 was $0.00.
- Adial Pharmaceuticals, Inc. operating leases, rent expense for the quarter ending 2017-09-30 was $750.00.
- Adial Pharmaceuticals, Inc. operating leases, rent expense for fiscal 2018 was $3.90K, a 420.00% increase from fiscal 2017.
- Adial Pharmaceuticals, Inc. operating leases, rent expense for fiscal 2017 was $750.00.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $3.90K derived: sum of 2 quarters · filed 2019-02-19 | $3.90K 10-K · filed 2019-02-19 | |
| 2018-09-30 | $3.90K 10-Q · filed 2018-11-14 | $3.90K 10-Q · filed 2018-11-14 | ||
| 2018-06-30 | $3.90K 10-Q · filed 2018-09-10 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $750.00 derived: sum of 2 quarters · filed 2019-02-19 | $750.00 10-K · filed 2019-02-19 | |
| 2017-09-30 | $750.00 10-Q · filed 2018-11-14 | $750.00 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $750.00 10-Q · filed 2018-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |